Trial intelligence / Profile preview

PSC-01 in Knee Osteoarthritis

NCT04043819Phase 1Unknown

Sponsor
Personalized Stem Cells
Start
Sep 2019
Primary completion
Jan 2021
Modality
Stem Cell Therapies
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of PSC-01 in osteoarthritis (OA), sponsored by Personalized Stem Cells. Primary endpoint: Incidence of Adverse Events. Status: unknown.

02

Drugs

PSC-01
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04043819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04043819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call